AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway.
The company vision is to provide novel antibiotic resistance breakers to meet the imminent threat to modern medicine of antimicrobial resistance (AMR).
AdjuTec's core technology is synthesis of β-lactamase inhibitors (BLIs) that inactivates bacteria resistance enzymes. By taking down bacteria defense we are able to preserve susceptibility of broad-spectrum antibiotics.
Supported by national and EU-grants as well as private funding AdjuTec has started preclinical development of its lead product APC148.
Location: Norway, Oslo
Employees: 1-10
Founded date: 2019
Investors 2
| Date | Name | Website |
| 27.01.2023 | Planet 9 C... | planet9ven... |
| - | Farvatn Ve... | farvatnven... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 29.05.2023 | Find your next investment at the BioStock Life Science Sprin... | Find your next investment at the BioStock Life Science Spring Summit on May 30 and 31! Mon, May 29,... | news.cisio... |